When compared to patients with advanced stage NSCLC and lymph node involvement, BCL11A expression was much higher in patients with early stage cancer and no lymph node involvement, which suggests that activation of the BCL11A proto-oncogene might be an early stage event in NSCLC. This evidence concerns the gene BCL11A and non-small cell lung carcinoma.